# Revvity, Inc. (RVTY)

- Sector: Healthcare · Industry: Diagnostics and Research
- SEC CIK: 0000031791 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000031791))
- Full page: https://inspectstocks.com/stocks/rvty
- Data as of: price 2026-09-29; newest filing used 2026-08-11; latest fiscal period ended 2026-07-05

## Grade

**A** on the growth-and-cash rubric, 5 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | passed | $2.9B | $2.8B |
| Revenue growing recently | passed | $2.9B | $2.9B |
| Free cash flow positive | passed | $558.1M |  |
| Free cash flow growing overall | passed | $558.1M | $153.2M |
| Free cash flow growing recently | passed | $558.1M | $509.4M |

Business quality (the + / − mark): 3 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | 8.2% |  |
| Healthy profit margin | failed | 8.2% |  |
| Strong operating margin | failed | 12.3% |  |
| Good return on equity | failed | 3.3% |  |
| Debt under control | passed | 0.47 |  |
| Turns sales into cash | passed | 19.2% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $2.9B |
| Net income, trailing twelve months | $237.6M |
| Free cash flow, trailing twelve months | $558.1M |
| Net margin | 8.2% |
| Operating margin | 12.3% |
| Return on equity | 3.3% |
| Debt to equity | 0.47 |
| Diluted EPS, trailing twelve months | $2.09 |
| Share price | $152.80 |
| Market value | $17.1B |
| Price / earnings | 73.1x |
| Price / sales | 5.9x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/rvty)
- [Financial statements](https://inspectstocks.com/stocks/rvty/financials)
- [Competitors](https://inspectstocks.com/stocks/rvty/peers)
- [Earnings](https://inspectstocks.com/stocks/rvty/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.